Old Web
English
Sign In
Acemap
>
authorDetail
>
Sergio Vegas-Suarez
Sergio Vegas-Suarez
University of the Basque Country
Parkinson's disease
Levodopa
Medicine
Buspirone
Basal ganglia
5
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The effect of 5‐HT1A receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
2021
British Journal of Pharmacology
Sergio Vegas-Suarez
Asier Aristieta
Catalina Requejo
Harkaitz Bengoetxea
José Vicente Lafuente
Cristina Miguelez
Luisa Ugedo
Show All
Source
Cite
Save
Citations (1)
The Noradrenergic System in Parkinson’s Disease
2020
Frontiers in Pharmacology
Elena Paredes-Rodriguez
Sergio Vegas-Suarez
Teresa Morera-Herreras
Philippe De Deurwaerdère
Cristina Miguelez
Show All
Source
Cite
Save
Citations (17)
Characterization of buspirone effect on output basal ganglia nuclei in 6-hydroxydopamine lesioned rats with and without long-term levodopa treatment.
2020
Sergio Vegas-Suarez
Show All
Source
Cite
Save
Citations (0)
6-hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata.
2020
British Journal of Pharmacology
Sergio Vegas-Suarez
Clarissa Anna Pisanò
C. Requejo
Harkaitz Bengoetxea
Jose V Lafuente
Michele Morari
Cristina Miguelez
Luisa Ugedo
Show All
Source
Cite
Save
Citations (4)
Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia
2019
International Review of Neurobiology
Sergio Vegas-Suarez
Elena Paredes-Rodriguez
Asier Aristieta
Jose V Lafuente
Cristina Miguelez
Luisa Ugedo
Show All
Source
Cite
Save
Citations (7)
1